Dechtman Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Dechtman Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $1,967 - $2,230	41 Added 0.99%	4,201 $227,000
Q4 2023 Jan 19, 2024	BUY	$48.48 - $57.85 $1,793 - $2,140	37 Added 0.9%	4,160 $213,000
Q3 2023 Oct 16, 2023	SELL	$57.89 - $64.73 $341,551 - $381,907	-5,900 Reduced 58.86%	4,123 $239,000
Q2 2023 Sep 08, 2023	BUY	$63.71 - $70.74 $638,565 - $709,027	10,023 New	10,023 $641 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dechtman Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dechtman Wealth Management, LLC with notifications on news.